William R. Wilson

Molecular Biology · 2004–2016

A researcher in the Science corpus: 3 papers; trusts 4 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 39 citations into it; #8,109 of 17,773 by trust here, #8,791 by citations
• Cancer Research — 33 citations into it; #435 of 1,780 by trust here, #696 by citations
• Biomedical Engineering — 7 citations into it

Whom William R. Wilson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. Semenza
2. Rakesh K. Jain
3. J. Tatum
4. J. Chiche
5. Amato J. Giaccia
6. A. Minchinton
7. Dana Branzei
8. P. Vaupel
9. Adrian L. Harris

Who trusts William R. Wilson overall

1. Asfar S. Azmi
2. Rakesh K. Jain
3. Bin Bao
4. C. Wigerup
5. Jiezhong Chen
6. S. Mckeown
7. D. Thommen
8. M. Nedeljković
9. Fazlul H. Sarkar
10. M. Egeblad

Papers from William R. Wilson's perspective

Ordered by how strongly the researchers William R. Wilson trusts endorse each paper. Same corpus, a different order for every researcher.

1. Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
2. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
3. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. (Cell Metabolism)
4. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. (Journal of Clinical Investigation)
5. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. (Cancer Cell)
6. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
7. Hypoxia-induced energy stress regulates mRNA translation and cell growth. (Molecules and Cells)
8. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. (Cancer Research)
9. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. (Genes & Development)
10. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. (Radiotherapy and Oncology)

Their papers

• Targeting hypoxia in cancer therapy (2011) — 2,914 citations
• Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. (2016) — 892 citations
• Exploiting tumour hypoxia in cancer treatment (2004) — 2,686 citations